The Swiss company reported a strong performance and a major boost in sales of its products.

A new study found a link between NovoNordisk’s blockbuster drug Ozempic and a reduced risk of Alzheimer’s disease. 23andMe, the company that popularized consumer genetic testing, could soon be delisted from the Nasdaq. And Novo Nordisk is asking the U.S. Food and Drug Administration (FDA) to bar compounding pharmacies

Read more...

Blockbuster diabetes and weight loss drugs, known as GLP-1 treatments, could help reduced the rate of overdoses and intoxications for people with substance use disorders, according to a new study published Thursday in the scientific journal Addiction. Walgreens announced this week that it will close another 1,200…

Read more...

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending by billions of dollars, according to a new report by the Congressional Budget Office (CBO). Amazon says that it plans to open pharmacies in 20 new cities across the U.S. in 2025. And some…

Read more...

The mayor of Rio de Janeiro is promising to make a generic version of Ozempic available through the city’s public health network — if he wins reelection. The top 5 highest-paid pharma CEOs all made over $60 million last year. And CVS Health Corporation (CVS) is set to slash 2,900 jobs as part of a multiyear, …

Read more...